Detalles de la búsqueda
1.
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
Am J Hum Genet;
109(6): 1140-1152, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659929
2.
Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women.
Am J Obstet Gynecol;
2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097030
3.
Non-invasive prenatal testing (NIPT) in twin pregnancies affected by early single fetal demise: A systematic review of NIPT and vanishing twins.
Prenat Diagn;
43(7): 829-837, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226326
4.
Decrease in Prevalence of Cleft lip, Alveolus and Palate After Nationwide Introduction of the Second-Trimester Anomaly Scan in the Netherlands.
Cleft Palate Craniofac J;
: 10556656221149144, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594216
5.
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
Am J Hum Genet;
105(6): 1091-1101, 2019 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708118
6.
Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review.
Prenat Diagn;
41(10): 1287-1295, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34350596
7.
Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study.
Prenat Diagn;
41(10): 1296-1304, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426993
8.
Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial.
Acta Obstet Gynecol Scand;
100(1): 109-118, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33319930
9.
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
Am J Hum Genet;
109(7): 1344, 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803237
10.
Prediction model of postnatal renal function in fetuses with lower urinary tract obstruction (LUTO)-Development and internal validation.
Prenat Diagn;
39(13): 1235-1241, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659787
11.
Antenatal Workup of Early Megacystis and Selection of Candidates for Fetal Therapy.
Fetal Diagn Ther;
45(3): 155-161, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29772579
12.
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
Lancet;
387(10033): 2117-2124, 2016 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26944026
13.
Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?
Am J Perinatol;
34(3): 234-239, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27441567
14.
Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.
Prenat Diagn;
36(12): 1083-1090, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27750376
15.
Pregnancy complications in singleton pregnancies with isolated fetal heart defects.
Acta Obstet Gynecol Scand;
95(11): 1273-1280, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496177
16.
Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
BMC Pregnancy Childbirth;
16(1): 154, 2016 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27405353
17.
Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).
BMC Pregnancy Childbirth;
16: 22, 2016 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26819104
18.
Authors' reply re: Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data.
BJOG;
127(11): 1439-1440, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32686891
19.
Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
Acta Obstet Gynecol Scand;
94(7): 715-721, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25845495
20.
Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
Am J Perinatol;
32(5): 451-60, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25486290